Read said Pfizer's mid- to late-stage drug pipeline "continues to strengthen with key potential opportunities, " including drugs for advanced breast cancer and three other types of cancer, one for high cholesterol and a meningococcal B vaccine for adolescents and young adults.
WSJ: Pfizer Q4 net jumps on sale of nutrition business